PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,057,860 | -23.9% | 653,000 | 0.0% | 0.25% | -39.3% |
| Q1 2023 | $1,390,890 | -74.3% | 653,000 | -55.3% | 0.42% | -77.8% |
| Q4 2022 | $5,402,000 | +133.0% | 1,460,000 | -53.1% | 1.88% | +96.2% |
| Q3 2022 | $2,318,000 | +8.8% | 3,115,000 | +13.7% | 0.96% | -0.4% |
| Q2 2022 | $2,131,000 | -2.9% | 2,740,000 | +13.0% | 0.96% | +40.9% |
| Q1 2022 | $2,195,000 | -80.9% | 2,425,000 | +68.9% | 0.68% | -72.0% |
| Q4 2021 | $11,498,000 | -3.5% | 1,435,510 | +0.8% | 2.44% | +9.5% |
| Q3 2021 | $11,921,000 | +28.1% | 1,424,200 | +3.2% | 2.23% | +44.1% |
| Q2 2021 | $9,304,000 | +8.0% | 1,380,400 | +5.9% | 1.54% | +22.1% |
| Q1 2021 | $8,613,000 | – | 1,303,000 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |